Trade Show News

MENLO PARK, Calif.--(BUSINESS WIRE)--Orca Bio today announced new data presented on its lead investigational allogeneic T-cell immunotherapy, Orca-T, at the 67th ASH Annual Meeting....

NORFOLK, Va.--(BUSINESS WIRE)--ReAlta Life Sciences, Inc. (“ReAlta” or the “Company”), a clinical-stage biopharmaceutical company dedicated to saving lives by rebalancing the inflammatory response to address rare and acute inflammatory diseases, today announced a presentation of interim Phase 2 clinical data on RLS-0071 (pegtarazimod) for the treatment of acute graft-versus-host disease (aGvHD) at the 67th American Society of Hematology (ASH) Annual Meeting. The new findings will be presented i...

CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) announced today that management will participate in investor meetings at Nareit’s REITworld 2025 Annual Conference (the “Nareit Conference”) on December 8-9, 2025. Written materials that the Company expects to use in connection with its participation at the Nareit Conference will be made available on the Company’s website on Monday, December 8, 2025 at 8:30 a.m. Eastern Time. Such materials will be archived at ir.ven...

STAMFORD, Conn.--(BUSINESS WIRE)--Webster Financial Corporation (NYSE:WBS), the holding company for Webster Bank, N.A., announced today that Chairman and CEO John Ciulla is scheduled to speak to investors at the Goldman Sachs 2025 Financial Services Conference, on Wednesday, December 10, at 12:20 p.m. ET. Comments will be accessible via live webcast on the Events page of Websters’ investor relations website at investors.websterbank.com. A replay will also be made available following the event....

TOKYO--(BUSINESS WIRE)--DIC Corporation will participate in CES 2026, one of the world’s leading technology trade shows and showcase prototypes of three innovative products....

BEDFORD, Mass. & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine, and Biogen Inc. (Nasdaq: BIIB) today announced data presentations that further support the potential of zorevunersen, an investigational antisense oligonucleotide, as a disease-modifying medicine for Dravet syndrome. These data were presented at the 2025 American Epilepsy Society (AES)...

SHANGHAI--(BUSINESS WIRE)--The “Four-Leaf Clover”, which the National Exhibition and Convention Center (NECC) shapes like, once again became the world’s business capital as the eighth China International Import Expo (CIIE) was held from November 5 to 10, 2025. This year, six guest countries of honor — Sweden, the United Arab Emirates (UAE), Colombia, Nigeria, Thailand, and Georgia — headlined the event, representing four continents and a shared commitment to open, sustainable growth. New Sectio...

IRVINE, Calif.--(BUSINESS WIRE)--Nihon Kohden, a global leader in neurodiagnostic technology, will showcase its integrated EEG portfolio at the American Epilepsy Society (AES) 2025 Annual Meeting, held December 5–9 in Atlanta. Attendees are invited to Booth #725 to explore solutions shaped through extensive collaboration with the clinicians who use them—bringing together mobility, connectivity and performance to advance neurological care. With a history of advancing EEG technology that predates...

PALO ALTO, Calif.--(BUSINESS WIRE)--Rubrik, Inc. (NYSE: RBRK), the Security and AI Operations Company, today announces that it is scheduled to present at the following investor conference: Barclays Global Technology Conference Location: San Francisco Date: Wednesday, December 10, 2025 Presentation Time: 9:15 a.m. PT The presentation will be webcast live and archived on the Company’s investor relations website at https://ir.rubrik.com. About Rubrik Rubrik (RBRK), the Security and AI Operations C...

LAS VEGAS--(BUSINESS WIRE)--At AWS re:Invent, Amazon Web Services, Inc. (AWS), an Amazon.com, Inc. company (NASDAQ: AMZN), today announced Amazon EC2 M9g instances powered by the new Graviton5 chip. Key takeaways New AWS Graviton5-based Amazon EC2 M9g instances deliver up to 25% higher performance than the previous generation. With 192 cores per chip and 5x larger cache, customers can scale up workloads and improve application performance while reducing infrastructure cost. For the third year i...